+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Contraceptive Market Research Report by Drugs, Gender, Distribution, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 125 Pages
  • October 2022
  • Region: United States
  • 360iResearch™
  • ID: 5122540
UP TO OFF until Dec 31st 2022
The United States Contraceptive Market size was estimated at USD 10.59 billion in 2021, USD 13.27 billion in 2022, and is projected to grow at a CAGR of 21.29% to reach USD 33.75 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Contraceptive to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drugs, the market was studied across Contraceptive Injectable, Emergency Contraceptive Pills, Oral Contraceptives, and Transdermal Patches.
  • Based on Gender, the market was studied across Female Contraceptive Devices and Male Contraceptive Devices.
  • Based on Distribution, the market was studied across Clinics, Hospital Pharmacy, Independent Pharmacy, and Online Platform.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies This research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Contraceptive market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Contraceptive Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Contraceptive Market, including Agile Therapeutics, Allergan Plc, Ani Pharmaceuticals Inc., Bayer Corporation, Church & Dwight Co., Inc., CooperSurgical, Inc., Fuji Latex Co. Ltd, Gilead Sciences Inc., Johnson & Johnson, Mayer Laboratories, Inc., Merck & Co. Inc., Pfizer Inc, Reckitt Benckiser Group Plc, Teva Pharmaceuticals Industries Ltd., and Veru Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Contraceptive Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Contraceptive Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Contraceptive Market?
4. What is the competitive strategic window for opportunities in the United States Contraceptive Market?
5. What are the technology trends and regulatory frameworks in the United States Contraceptive Market?
6. What is the market share of the leading vendors in the United States Contraceptive Market?
7. What modes and strategic moves are considered suitable for entering the United States Contraceptive Market?
Frequently Asked Questions about the U.S. Contraceptive Market

What is the estimated value of the U.S. Contraceptive Market?

The U.S. Contraceptive Market was estimated to be valued at $10.59 Billion in 2021.

What is the growth rate of the U.S. Contraceptive Market?

The growth rate of the U.S. Contraceptive Market is 21.2%, with an estimated value of $33.75 Billion by 2027.

What is the forecasted size of the U.S. Contraceptive Market?

The U.S. Contraceptive Market is estimated to be worth $33.75 Billion by 2027.

Who are the key companies in the U.S. Contraceptive Market?

Key companies in the U.S. Contraceptive Market include Agile Therapeutics, Allergan Plc, Ani Pharmaceuticals Inc., Bayer Corporation, Church & Dwight Co., Inc., CooperSurgical, Inc., Fuji Latex Co. Ltd, Gilead Sciences Inc. and Mayer Laboratories, Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Contraceptive Market, by Drugs
6.1. Introduction
6.2. Contraceptive Injectable
6.3. Emergency Contraceptive Pills
6.4. Oral Contraceptives
6.5. Transdermal Patches
7. Contraceptive Market, by Gender
7.1. Introduction
7.2. Female Contraceptive Devices
7.3. Male Contraceptive Devices
8. Contraceptive Market, by Distribution
8.1. Introduction
8.2. Clinics
8.3. Hospital Pharmacy
8.4. Independent Pharmacy
8.5. Online Platform
9. California Contraceptive Market
9.1. Introduction
10. Florida Contraceptive Market
10.1. Introduction
11. Illinois Contraceptive Market
11.1. Introduction
12. New York Contraceptive Market
12.1. Introduction
13. Ohio Contraceptive Market
13.1. Introduction
14. Pennsylvania Contraceptive Market
14.1. Introduction
15. Texas Contraceptive Market
15.1. Introduction
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Agile Therapeutics
17.1.1. Business Overview
17.1.2. Key Executives
17.1.3. Product & Services
17.2. Allergan Plc
17.2.1. Business Overview
17.2.2. Key Executives
17.2.3. Product & Services
17.3. Ani Pharmaceuticals Inc.
17.3.1. Business Overview
17.3.2. Key Executives
17.3.3. Product & Services
17.4. Bayer Corporation
17.4.1. Business Overview
17.4.2. Key Executives
17.4.3. Product & Services
17.5. Church & Dwight Co., Inc.
17.5.1. Business Overview
17.5.2. Key Executives
17.5.3. Product & Services
17.6. CooperSurgical, Inc.
17.6.1. Business Overview
17.6.2. Key Executives
17.6.3. Product & Services
17.7. Fuji Latex Co. Ltd
17.7.1. Business Overview
17.7.2. Key Executives
17.7.3. Product & Services
17.8. Gilead Sciences Inc.
17.8.1. Business Overview
17.8.2. Key Executives
17.8.3. Product & Services
17.9. Johnson & Johnson
17.9.1. Business Overview
17.9.2. Key Executives
17.9.3. Product & Services
17.10. Mayer Laboratories, Inc.
17.10.1. Business Overview
17.10.2. Key Executives
17.10.3. Product & Services
17.11. Merck & Co. Inc.
17.11.1. Business Overview
17.11.2. Key Executives
17.11.3. Product & Services
17.12. Pfizer Inc
17.12.1. Business Overview
17.12.2. Key Executives
17.12.3. Product & Services
17.13. Reckitt Benckiser Group Plc
17.13.1. Business Overview
17.13.2. Key Executives
17.13.3. Product & Services
17.14. Teva Pharmaceuticals Industries Ltd.
17.14.1. Business Overview
17.14.2. Key Executives
17.14.3. Product & Services
17.15. Veru Inc.
17.15.1. Business Overview
17.15.2. Key Executives
17.15.3. Product & Services
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES CONTRACEPTIVE MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES CONTRACEPTIVE MARKET SIZE, 2021 VS 2027
FIGURE 3. UNITED STATES CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 4. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 6. UNITED STATES CONTRACEPTIVE MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 7. UNITED STATES CONTRACEPTIVE MARKET DYNAMICS
FIGURE 8. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2021 VS 2027 (USD BILLION)
FIGURE 10. UNITED STATES CONTRACEPTIVE MARKET COMPETITIVE STRATEGIC WINDOW, BY DRUGS, 2027
FIGURE 11. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTABLE, 2018-2027 (USD BILLION)
FIGURE 12. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVE PILLS, 2018-2027 (USD BILLION)
FIGURE 13. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2027 (USD BILLION)
FIGURE 14. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2027 (USD BILLION)
FIGURE 15. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2021 VS 2027 (%)
FIGURE 16. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2021 VS 2027 (USD BILLION)
FIGURE 17. UNITED STATES CONTRACEPTIVE MARKET COMPETITIVE STRATEGIC WINDOW, BY GENDER, 2027
FIGURE 18. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY FEMALE CONTRACEPTIVE DEVICES, 2018-2027 (USD BILLION)
FIGURE 19. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY MALE CONTRACEPTIVE DEVICES, 2018-2027 (USD BILLION)
FIGURE 20. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (%)
FIGURE 21. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (USD BILLION)
FIGURE 22. UNITED STATES CONTRACEPTIVE MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION, 2027
FIGURE 23. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY CLINICS, 2018-2027 (USD BILLION)
FIGURE 24. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2027 (USD BILLION)
FIGURE 25. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, 2018-2027 (USD BILLION)
FIGURE 26. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, 2018-2027 (USD BILLION)
FIGURE 27. CALIFORNIA CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 28. FLORIDA CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 29. ILLINOIS CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 30. NEW YORK CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 31. OHIO CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 32. PENNSYLVANIA CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 33. TEXAS CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 34. UNITED STATES CONTRACEPTIVE MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 35. UNITED STATES CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 36. UNITED STATES CONTRACEPTIVE MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. UNITED STATES CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. UNITED STATES CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 4. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2018-2027 (USD BILLION)
TABLE 5. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2027 (USD BILLION)
TABLE 6. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTABLE, 2018-2027 (USD BILLION)
TABLE 7. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTABLE, BY STATE, 2018-2027 (USD BILLION)
TABLE 8. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVE PILLS, 2018-2027 (USD BILLION)
TABLE 9. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVE PILLS, BY STATE, 2018-2027 (USD BILLION)
TABLE 10. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2027 (USD BILLION)
TABLE 11. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVES, BY STATE, 2018-2027 (USD BILLION)
TABLE 12. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2027 (USD BILLION)
TABLE 13. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL PATCHES, BY STATE, 2018-2027 (USD BILLION)
TABLE 14. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2027 (USD BILLION)
TABLE 15. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY FEMALE CONTRACEPTIVE DEVICES, 2018-2027 (USD BILLION)
TABLE 16. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY FEMALE CONTRACEPTIVE DEVICES, BY STATE, 2018-2027 (USD BILLION)
TABLE 17. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY MALE CONTRACEPTIVE DEVICES, 2018-2027 (USD BILLION)
TABLE 18. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY MALE CONTRACEPTIVE DEVICES, BY STATE, 2018-2027 (USD BILLION)
TABLE 19. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 20. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY CLINICS, 2018-2027 (USD BILLION)
TABLE 21. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY STATE, 2018-2027 (USD BILLION)
TABLE 22. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2027 (USD BILLION)
TABLE 23. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2018-2027 (USD BILLION)
TABLE 24. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, 2018-2027 (USD BILLION)
TABLE 25. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY STATE, 2018-2027 (USD BILLION)
TABLE 26. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, 2018-2027 (USD BILLION)
TABLE 27. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY STATE, 2018-2027 (USD BILLION)
TABLE 28. CALIFORNIA CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 29. CALIFORNIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2027 (USD BILLION)
TABLE 30. CALIFORNIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2027 (USD BILLION)
TABLE 31. CALIFORNIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 32. FLORIDA CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 33. FLORIDA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2027 (USD BILLION)
TABLE 34. FLORIDA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2027 (USD BILLION)
TABLE 35. FLORIDA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 36. ILLINOIS CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 37. ILLINOIS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2027 (USD BILLION)
TABLE 38. ILLINOIS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2027 (USD BILLION)
TABLE 39. ILLINOIS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 40. NEW YORK CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 41. NEW YORK CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2027 (USD BILLION)
TABLE 42. NEW YORK CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2027 (USD BILLION)
TABLE 43. NEW YORK CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 44. OHIO CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 45. OHIO CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2027 (USD BILLION)
TABLE 46. OHIO CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2027 (USD BILLION)
TABLE 47. OHIO CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 48. PENNSYLVANIA CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 49. PENNSYLVANIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2027 (USD BILLION)
TABLE 50. PENNSYLVANIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2027 (USD BILLION)
TABLE 51. PENNSYLVANIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 52. TEXAS CONTRACEPTIVE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 53. TEXAS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2027 (USD BILLION)
TABLE 54. TEXAS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2027 (USD BILLION)
TABLE 55. TEXAS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2027 (USD BILLION)
TABLE 56. UNITED STATES CONTRACEPTIVE MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 57. UNITED STATES CONTRACEPTIVE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 58. UNITED STATES CONTRACEPTIVE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 59. UNITED STATES CONTRACEPTIVE MARKET RANKING, BY KEY PLAYER, 2021
TABLE 60. UNITED STATES CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2021
TABLE 61. UNITED STATES CONTRACEPTIVE MARKET MERGER & ACQUISITION
TABLE 62. UNITED STATES CONTRACEPTIVE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 63. UNITED STATES CONTRACEPTIVE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 64. UNITED STATES CONTRACEPTIVE MARKET INVESTMENT & FUNDING
TABLE 65. UNITED STATES CONTRACEPTIVE MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 66. UNITED STATES CONTRACEPTIVE MARKET: LICENSE & PRICING

Companies Mentioned

  • Agile Therapeutics
  • Allergan Plc
  • Ani Pharmaceuticals Inc.
  • Bayer Corporation
  • Church & Dwight Co., Inc.
  • CooperSurgical, Inc.
  • Fuji Latex Co. Ltd
  • Gilead Sciences Inc.
  • Johnson & Johnson
  • Mayer Laboratories, Inc.
  • Merck & Co. Inc.
  • Pfizer Inc
  • Reckitt Benckiser Group Plc
  • Teva Pharmaceuticals Industries Ltd.
  • Veru Inc.

Methodology

Loading
LOADING...